Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Perlman

Showing results (241-250 of 275) with videos related to

Pageof 28
Sort By:
Journal of Medicinal Chemistry|December 6, 2021
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based StudiesChamandi S Dampalla, Athri D Rathnayake, Krishani Dinali Perera, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19Lok-Yin Roy Wong, Jian Zheng, Kevin Wilhelmsen, et al.
Vaccine|December 21, 2025
Initiation of a coronavirus vaccine libraryDory Kovacs, Gurpreet Brar, Simon J Anthony, et al.
Journal of Infection and Public Health|May 27, 2022
COVID-19 breakthrough infections in rheumatic diseases patients after vaccinationAbeer N Alshukairi, Awad Al-Omari, Abdurahman Albeity, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2Gang Ye, Joseph P Gallant, Christopher Massey, et al.
Mbio|May 24, 2018
Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and PathogenesisCarlos Castaño-Rodriguez, Jose M Honrubia, Javier Gutiérrez-Álvarez, et al.
EMBO Molecular Medicine|March 22, 2023
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responsesValeria Fumagalli, Pietro Di Lucia, Micol Ravà, et al.
Iscience|March 4, 2025
Complement is primarily activated in the lung in a mouse model of severe COVID-19Peter J Szachowicz, Christine Wohlford-Lenane, Cobey J Donelson, et al.
Mbio|January 10, 2023
SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator ModulatorsJose M Honrubia, Javier Gutierrez-Álvarez, Alejandro Sanz-Bravo, et al.
Journal of Medical Virology|October 22, 2022
Development and characterization of a new monoclonal antibody against SARS-CoV-2 NSP12 (RdRp)Wen Meng, Siying Guo, Simon Cao, et al.
Pageof 28

Showing results (241-250 of 275) with videos related to

Sort By:
Pageof 28
Journal of Medicinal Chemistry|December 6, 2021
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based StudiesChamandi S Dampalla, Athri D Rathnayake, Krishani Dinali Perera, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19Lok-Yin Roy Wong, Jian Zheng, Kevin Wilhelmsen, et al.
Vaccine|December 21, 2025
Initiation of a coronavirus vaccine libraryDory Kovacs, Gurpreet Brar, Simon J Anthony, et al.
Journal of Infection and Public Health|May 27, 2022
COVID-19 breakthrough infections in rheumatic diseases patients after vaccinationAbeer N Alshukairi, Awad Al-Omari, Abdurahman Albeity, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2Gang Ye, Joseph P Gallant, Christopher Massey, et al.
Mbio|May 24, 2018
Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and PathogenesisCarlos Castaño-Rodriguez, Jose M Honrubia, Javier Gutiérrez-Álvarez, et al.
EMBO Molecular Medicine|March 22, 2023
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responsesValeria Fumagalli, Pietro Di Lucia, Micol Ravà, et al.
Iscience|March 4, 2025
Complement is primarily activated in the lung in a mouse model of severe COVID-19Peter J Szachowicz, Christine Wohlford-Lenane, Cobey J Donelson, et al.
Mbio|January 10, 2023
SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator ModulatorsJose M Honrubia, Javier Gutierrez-Álvarez, Alejandro Sanz-Bravo, et al.
Journal of Medical Virology|October 22, 2022
Development and characterization of a new monoclonal antibody against SARS-CoV-2 NSP12 (RdRp)Wen Meng, Siying Guo, Simon Cao, et al.
Pageof 28